BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision ...

AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with quantum computing, that's all changing.

In conclusion, exosomes represent a groundbreaking innovation in skincare and regenerative medicine, offering transformative potential for skin rejuvenation, anti-aging, and wound healing. Their ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and patient outcomes in healthcare.

Drug discovery and development is notoriously sluggish. Now, big data and AI promise to make some steps in the pipeline up to ten times faster.

How machine learning in drug discovery is revolutionizing pharmaceutical research By leveraging AI and machine learning, companies can now conduct millions of experiments simultaneously.

Personal care and cosmetic products play a significant role in our daily lives, enhancing our appearance and self-confidence. However, beneath their aesthetic appeal lies a growing concern regarding ...

This article explores a range of target protein design, development, and characterization strategies, highlighting their central role in the discovery of highly specific monoclonal antibodies with ...

Failure rates remain staggeringly high even with billions of dollars being invested in research and development (R&D). Between 70% and 90% of drug candidates will fail.

Google DeepMind has announced the launch of TxGemma, an open collection of AI models designed to enhance the efficiency of drug discovery and clinical trial predictions. Built on the Gemma model ...

SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has launched the next generation of its multi-omics and real ...